BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 16242252)

  • 1. Preoperative radiation with concurrent chemotherapy for resectable rectal cancer: effect of dose escalation on pathologic complete response, local recurrence-free survival, disease-free survival, and overall survival.
    Wiltshire KL; Ward IG; Swallow C; Oza AM; Cummings B; Pond GR; Catton P; Kim J; Ringash J; Wong CS; Wong R; Siu LL; Moore M; Brierley J
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(3):709-16. PubMed ID: 16242252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short versus conventional preoperative radiotherapy of rectal cancer: indications.
    Klenova A; Georgiev R; Kurtev P; Kurteva G
    J BUON; 2007; 12(2):227-32. PubMed ID: 17600877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomised clinical trial of adjuvant postoperative RT vs. sequential postoperative RT plus 5-FU and levamisole in patients with stage II-III resectable rectal cancer: a final report.
    Cafiero F; Gipponi M; Lionetto R;
    J Surg Oncol; 2003 Jul; 83(3):140-6. PubMed ID: 12827681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Posttreatment TNM staging is a prognostic indicator of survival and recurrence in tethered or fixed rectal carcinoma after preoperative chemotherapy and radiotherapy.
    Chan AK; Wong A; Jenken D; Heine J; Buie D; Johnson D
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):665-77. PubMed ID: 15708244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized controlled trial of postoperative radiotherapy and short-term time-scheduled 5-fluorouracil against surgery alone in the treatment of Dukes B and C rectal cancer. Norwegian Adjuvant Rectal Cancer Project Group.
    Tveit KM; Guldvog I; Hagen S; Trondsen E; Harbitz T; Nygaard K; Nilsen JB; Wist E; Hannisdal E
    Br J Surg; 1997 Aug; 84(8):1130-5. PubMed ID: 9278661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative chemoradiotherapy and total mesorectal excision surgery for locally advanced rectal cancer: correlation with rectal cancer regression grade.
    Wheeler JM; Dodds E; Warren BF; Cunningham C; George BD; Jones AC; Mortensen NJ
    Dis Colon Rectum; 2004 Dec; 47(12):2025-31. PubMed ID: 15657650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term results of a phase II trial of high-dose radiotherapy (60 Gy) and UFT/l-leucovorin in patients with non-resectable locally advanced rectal cancer (LARC).
    Vestermark LW; Jacobsen A; Qvortrup C; Hansen F; Bisgaard C; Baatrup G; Rasmussen P; Pfeiffer P
    Acta Oncol; 2008; 47(3):428-33. PubMed ID: 18348002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-fluorouracil-based chemoradiation in unresectable pancreatic carcinoma: Phase I-II dose-escalation study.
    Morganti AG; Valentini V; Macchia G; Mattiucci GC; Costamagna G; Deodato F; Smaniotto D; Luzi S; Balducci M; Barbi S; Perri V; Trodella L; Cellini N
    Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1454-60. PubMed ID: 15275732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative chemotherapy and radiotherapy for locally advanced rectal cancer.
    Chao M; Gibbs P; Tjandra J; Cullinan M; McLaughlin S; Faragher I; Skinner I; Jones I
    ANZ J Surg; 2005 May; 75(5):286-91. PubMed ID: 15932438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized, multicenter, phase IIb study of preoperative chemoradiotherapy in T3 mid-distal rectal cancer: raltitrexed + oxaliplatin + radiotherapy versus cisplatin + 5-fluorouracil + radiotherapy.
    Valentini V; Coco C; Minsky BD; Gambacorta MA; Cosimelli M; Bellavita R; Morganti AG; La Torre G; Trodella L; Genovesi D; Portaluri M; Maurizi-Enrici R; Barbera F; Maranzano E; Lupattelli M
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):403-12. PubMed ID: 17919844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiochemotherapy in combination with regional hyperthermia in preirradiated patients with recurrent rectal cancer.
    Milani V; Pazos M; Issels RD; Buecklein V; Rahman S; Tschoep K; Schaffer P; Wilkowski R; Duehmke E; Schaffer M
    Strahlenther Onkol; 2008 Mar; 184(3):163-8. PubMed ID: 18330513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative radiotherapy in rectal cancer: treatment results of three different dose regimens.
    Klenova A; Parvanova V; Georgiev R; Gesheva N
    J BUON; 2006; 11(2):161-6. PubMed ID: 17318965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I study of 5-fluorouracil and leucovorin by continuous infusion chronotherapy and pelvic radiotherapy in patients with locally advanced or recurrent rectal cancer.
    Parulekar W; de Marsh RW; Wong R; Mendenhall W; Davey P; Zlotecki R; Berry S; Rout WR; Bjarnason GA
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1487-95. PubMed ID: 15050328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A simplified tumor regression grade correlates with survival in locally advanced rectal carcinoma treated with neoadjuvant chemoradiotherapy.
    Beddy D; Hyland JM; Winter DC; Lim C; White A; Moriarty M; Armstrong J; Fennelly D; Gibbons D; Sheahan K
    Ann Surg Oncol; 2008 Dec; 15(12):3471-7. PubMed ID: 18846402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postoperative chemoradiotherapy in rectal cancer. Late results of a pilot study.
    Tersigni R; Alessandroni L; Arcangeli G; Baiano G; Marini P; Micheli A; Sorgi G
    Hepatogastroenterology; 2004; 51(60):1679-85. PubMed ID: 15532804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II trial of preoperative chemoradiation with a hyperfractionated radiation boost in locally advanced rectal cancer.
    Movsas B; Diratzouian H; Hanlon A; Cooper H; Freedman G; Konski A; Sigurdson E; Hoffman J; Meropol NJ; Weiner LM; Coia L; Lanciano R; Stein J; Kister D; Eisenberg B
    Am J Clin Oncol; 2006 Oct; 29(5):435-41. PubMed ID: 17023775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemoradiotherapy followed by surgery in rectal cancer: improved local control using a moderately high pelvic radiation dose.
    Lee SH; Lee KC; Choi JH; Oh JH; Baek JH; Park SH; Shin DB
    Jpn J Clin Oncol; 2008 Feb; 38(2):112-21. PubMed ID: 18263881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203.
    Gérard JP; Conroy T; Bonnetain F; Bouché O; Chapet O; Closon-Dejardin MT; Untereiner M; Leduc B; Francois E; Maurel J; Seitz JF; Buecher B; Mackiewicz R; Ducreux M; Bedenne L
    J Clin Oncol; 2006 Oct; 24(28):4620-5. PubMed ID: 17008704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between pathologic response in metastatic lymph nodes after preoperative chemoradiotherapy and risk of distant metastases in rectal cancer: An analysis of outcomes in a randomized trial.
    Bujko K; Michalski W; Kepka L; Nowacki MP; Nasierowska-Guttmejer A; Tokar P; Dymecki D; Pawlak M; Lesniak T; Richter P; Wojnar A; Chmielik E;
    Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):369-77. PubMed ID: 17118570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.